Back to Results
First PageMeta Content
FDA Fast Track Development Program / Pharmaceutical industry / Health / Inclusion body myositis / Novartis


Global Press Release Template Color logo August 2010
Add to Reading List

Document Date: 2013-11-03 00:53:06


Open Document

File Size: 225,34 KB

Share Result on Facebook

City

Basel / /

Company

Novartis International AG / Novartis Group / Novartis Pharmaceuticals / Novartis AG / Twitter / /

Continent

North America / Europe / /

Country

Switzerland / United States / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

HuCAL library / /

IndustryTerm

over-the-counter and animal health products / generic pharmaceuticals / diagnostic tools / healthcare solutions / /

MedicalCondition

sporadic inclusion body myositis / Inclusion-body myositis / malnutrition / aspiration pneumonia / cancer / disease / chronic obstructive pulmonary disease / serious disease / rare disease / common degenerative disease / infection / injuries / /

MedicalTreatment

intravenous infusion / investigational treatment / /

Organization

US Securities and Exchange Commission / American Neurological Association / US Food and Drug Administration / FDA / /

Person

Timothy Wright / Stephen Rubino Jill Pozarek / Barbara Duci / Samir Shah Pierre-Michel Bringer / Thomas Hungerbuehler Isabella Zinck / /

/

Position

Global Head of Development / general public pricing pressures / /

Product

BYM338 / /

URL

http /

SocialTag